What is Photosensitizer Drug Market?
Photosensitizers are the chemical components/drugs which are used along with the light to treat different types of cancers. Photosensitizers absorb the light and change into another form which in turn destroys the cancer cells. Photosensitizer drugs are used in photodynamic therapy for the treatment of cancer. These agents are exposed to a specific wavelength of light to produce an active form of oxygen that kills nearby cancer cells. Various forms of photosensitizer drugs include porphyrin derivatives, Aminolevulinic acid (ALA), chlorines, and others.
The market study is being classified by Type (Porphyrin Derivatives (PD) (Hematoporphyrin Derivative (HpD), Benzoporphyrin Derivative (BPD), Texaphyrins, Others), Aminolevulinic acid (ALA), Chlorines and Others), by Application (Cancer (Basal Cell Carcinoma, Non-small Cell Lung Cancer, Head & Neck Cancer, Others), Actinic Keratosis (AK), Psoriasis, Acne and Others) and major geographies with country level break-up.
Sanofi S.A (France), DUSA Pharmaceuticals, Inc. (United States), Bausch Health Companies Inc. (United States), Beiersdorf AG (Germany), Soligenix, Inc. (United States), Theralase Technologies (Canada), Quest Pharmatech (Canada), Galderma (Switzerland) and Biofrontera (Germany) are some of the key players profiled in the study.
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that Global Players will contribute to the maximum growth of Global Photosensitizer Drug market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Photosensitizer Drug market by Type, Application and Region.
On the basis of geography, the market of Photosensitizer Drug has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increase in the Prevalence of Cancers
- Rise in the Burden of Dermatology Disorders
- Development of Healthcare Infrastructure in Emerging Economies
- Increasing Awareness among People about Preventive Healthcare
- Side Effects of the Photosensitizer Drug
- Growing R&D Investment by the Market Players
- Rising Attention toward New Anti-cancer Therapies
- Strigent Government Rules and Regulations
In Oct 2019, Theralase® Technologies Inc is pleased to announce that the Company has been granted a European Patent for its anti-cancer PDCs, which will issue in due course.
Key Target AudienceManufacturers of Photosensitizer Drug, Suppliers and Distributors of Photosensitizer Drug, Potential Investors, Market Research Firms, Regulatory Bodies, End-Users and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase